{"Title": "Brain atrophy measurements should be used to guide therapy monitoring in MS - Commentary", "Year": 2016, "Source": "Mult. Scler.", "Volume": "22", "Issue": 12, "Art.No": null, "PageStart": 1526, "PageEnd": 1527, "CitedBy": 2, "DOI": "10.1177/1352458516656061", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84991396696&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Atrophy", "Brain", "Brain Diseases", "Humans", "Magnetic Resonance Imaging", "Multiple Sclerosis"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 2, "EID": "2-s2.0-84991396696", "SubjectAreas": [["Neurology", "NEUR", "2808"], ["Neurology (clinical)", "MEDI", "2728"]], "AuthorData": {"7004057758": {"Name": "Chard D.", "AuthorID": "7004057758", "AffiliationID": "60024544, 60172638", "AffiliationName": "National Institute for Health Research (NIHR), Biomedical Research Centre, University College London Hospitals (UCLH)"}}}